Participate in Research

Study for Head and Neck Cancer Survivors with Dry Mouth
Protocol: STUDY00007449
Full Title
A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of AAV2-hAQP1 Gene Therapy in Participants with Radiation-Induced Late Xerostomia
Erie County Medical Center is recruiting head and neck cancer survivors for the AQUAx2 study. The goal of this study is to determine how effective a new study drug (AAV2-hAQP1) is at helping with dry mouth (xerostomia) caused by radiation therapy.

Participants will be in this study for 1 year. They will be randomly assigned (which happens by chance, like flipping a coin) to one of three study conditions: two groups will receive different concentrations of the study drug and the third group will receive a placebo (which looks like the study drug but does not contain any active medication). Throughout the study, participants will complete physical exams, surveys, saliva/urine collections, and blood draws.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Adults over the age of 18 years old Have previously completed radiation therapy for head or neck cancer Have not had head or neck cancer for at least 3 years Have not been diagnosed with any other types of cancer
Age Group: Adults
Principal Investigator: JENNIFER FRUSTINO
+1 716-888-4843
+1 716-898-3000
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions